What is true about dexmedetomidine's respiratory effects?

What is true about dexmedetomidine's respiratory effects?

• A. No respiratory depression, no change in oxygenation, blood pH, or CO2 response curve
• B. Significant respiratory depression
• C. Decreased oxygenation
• D. Increased slope of CO2 response curve

Answer: (A)

Dexmedetomidine sedates without substantially depressing respiration because it acts on alpha-2 receptors in the locus coeruleus to produce a sleep-like state while sparing the medullary respiratory centers. This means patients typically maintain spontaneous breathing, keep adequate oxygenation, and preserve normal acid-base status. The CO2 drive to breathe remains intact, so there isn’t a meaningful change in the CO2 response curve. In practice, this makes dexmedetomidine unique among sedatives, providing sedation with minimal impact on ventilation and gas exchange. With typical dosing and when not combined with other respiratory depressants, you don’t see significant respiratory depression, hypoxemia, or a shift in pH due to altered ventilation.

Dexmedetomidine sedates without substantially depressing respiration because it acts on alpha-2 receptors in the locus coeruleus to produce a sleep-like state while sparing the medullary respiratory centers. This means patients typically maintain spontaneous breathing, keep adequate oxygenation, and preserve normal acid-base status. The CO2 drive to breathe remains intact, so there isn’t a meaningful change in the CO2 response curve. In practice, this makes dexmedetomidine unique among sedatives, providing sedation with minimal impact on ventilation and gas exchange. With typical dosing and when not combined with other respiratory depressants, you don’t see significant respiratory depression, hypoxemia, or a shift in pH due to altered ventilation.